top biotech venture capital firms 2021

The firms themselves are the sources of much of the information, though in some instances, amounts of capital under management were calculated by adding the value of newly closed funds with previously disclosed amounts. Essex Woodlands Health Ventures, City (cities) where offices are located: Palo Alto, CA; Houston; New York; London; Shanghai, Fund size and status: More than $2.5 billion under management across eight funds (4), Current fund: $900 million Fund VIII, closed 2009 (4), Current biopharma portfolio companies: Acura Pharmaceuticals, Biotoscana, Bioventus, Catalyst Biosciences, Chroma Therapeutics, Corium, Curis, Echo Therapeutics, Elusys Therapeutics, Horizon Pharma, IntegenX, LightSciences Oncology, Medicinova, Molecular Partners, Open Monoclonal Technology, Oraya Therapeutics, Revance Therapeutics, Symphogen, Ziopharm Oncology, City (cities) where offices are located: Cambridge, MA; New York; Palo Alto, CA, Fund size and status: $2.6 billion under management across seven funds, Current funds: $450 million Venrock VII, closed July 2014 and intended to invest in technology and healthcare companies; $350 million Venrock VI, closed 2010 (5), Current biopharma portfolio companies: Acceleron Pharma, Achaogen, Anacor Pharmaceuticals, Ariosa Diagnostics, Avalanche Biotech, AVEO Pharmaceuticals, Celladon, Cerulean, Constellation Pharmaceuticals, CymaBay Therapeutics, Fate Therapeutics, Hua Medicine, Infinity Pharmaceuticals, Intarcia Therapeutics, Ironwood Pharma, Juno Therapeutics, QuatRx Pharmaceuticals, Receptos, Vitae Pharmaceuticals, City (cities) where offices are located: Boston (6); South San Francisco, CA; Gainesville, FL; Munich, Fund size and status: More than $2.6 billion committed capital under management across five funds, Current fund: Approximately $300 million MPM BioVentures V L.P., closed 2010 (7), Current biopharma portfolio companies: 23andMe, Amphivena Therapeutics, Anthera Pharmaceuticals, Aratana Therapeutics, Astute Medical, Celladon, Cerecor, Chiasma, Conatus Pharmaceuticals, Epizyme, Iconic Therapeutics, Mitokyne, Proteon Therapeutics, Radius Health, Rhythm Pharmaceuticals, SAI, Selexys Pharmaceuticals, Sideris Pharmaceuticals, Solasia Pharma, Syndax Pharmaceuticals, Theraclone Sciences, True North Therapeutics, Vascular Pharmaceuticals, Verastem, City (cities) where offices are located: Princeton, NJ, and San Diego, Fund size and status: More than $2.7 billion under management across eight funds, Current fund: $500 million Domain Partners VIII, closed 2009, Current biopharma portfolio companies: Achaogen, Achillion Pharmaceuticals, Adynxx, Afferent Pharmaceuticals, Aldeyra Therapeutics, Alimera Sciences, Applied Proteomics, Ariosa Diagnostics, Ascenta Therapeutics, Asmacure, Astute Medical, Atara Biotherapeutics, aTyr Pharma, BioNano Genomics, Cantex Pharmaceuticals, Celator Pharmaceuticals, Clovis Oncology, CoDa Therapeutics, CoLucid Pharmaceuticals, Dicerna Pharmaceuticals, Domain Elite Holdings, Domain Russia Investments, Eddingpharm International Holdings, Epic Sciences, Esperion Therapeutics, Evoke Pharma, Five Prime Therapeutics, IntegenX, Marinus Pharmaceuticals, Meritage Pharma, NovaDigm Therapeutics, Ocera Therapeutics, Oraya Therapeutics, Orexigen Therapeutics, Otonomy, ProteinSimple, Regardo Biosciences, Sera Prognostics, Syndax Pharmaceuticals, Tobira Therapeutics, Tragara Pharmaceuticals, VentiRx Pharmaceuticals, Veracyte, Zogenix, Fund size and status: $2.8 billion under management across 10 funds, Current fund: $650 million InterWest Partners X, closed 2008, Current biopharma portfolio companies: Applied Genetic Technologies (AGTC), Alvine Pharmaceuticals, Arcion Therapeutics, Carbylan Therapeutics, Cebix, Centrexion, Cidara Therapeutics, Drais Pharmaceuticals, Eiger BioPharmaceuticals, Lycera, MacroGenics, Ocera Therapeutics, On Demand Therapeutics, Paratek Pharmaceuticals, PMV Pharma, QuatRx Pharmaceuticals, RadioRx, Tesaro, Trius Therapeutics, USDS, Xenon Pharmaceuticals, City (cities) where offices are located: Cambridge, MA. WebThe organization aims to help startup companies commercialize new medical technologies by providing access to the vast resources of the worlds largest medical center. The Indian startup/ VC ecosystem will truly come of age The firm seeks to make investments in companies operating in business software, consumer internet, cloud service, enterprise software and other technology sectors. Here is a list of the most active most active bio-tech, pharma and life science investors. The Legal 500; United States . , which conducts research and development of pharmaceuticals related to COVID-19. Founded in 2014, Geekdom Fund is a venture capital firm based in San Antonio, Texas. The companys life science and healthcare investment portfolio spans the Biopharmaceutical, Biotechnology, medical equipment, services, and information and technology industries. Kleiner Perkins Caufield & Byers (KPCB), City (cities) where offices are located: Menlo Park, CA; San Francisco; Beijing; Shanghai, Fund size and status: More than $7 billion in assets under management across 19 funds (13), Current fund: $525 million KPCB XV, closed 2012 (13), Current biopharma portfolio companies:(14) ApniCure, Armo BioSciences, Atara Bio, Auxogyn, Crescendo Bioscience, Elcelyx, Epizyme, FivePrime Therapeutics, Focal, Foundation Medicine, Oculeve, Onyx Pharmaceuticals, Orexigen, Pacific Biosciences, Pharmacopeia, Pharmacyclics, Practice Fusion, Rapid Micro Biosystems, Tesaro, True North Therapeutics. With $19 billion in assets under management, OrbiMed is set to be a leader next year as well. 1. CRO. CFO Alyssa Dadoly, Partners Kip Mcclanahan, Mike Dodd, Morgan Flager, and Roger Chen. US biotechs still led on investments, although Europe Healthtech and biotech has consistently been a top sector for the destination of venture capital in recent years. Find the right companies, identify the right contacts, and connect with decision-makers with an all-in-one prospecting solution. The firm primarily works in the Biopharma industry and has a remarkable in-house scientific breakthrough research facility called Versants Discovery Engines. The Legal 500; Europe, Middle East & Africa . Founded in 2014, ATX Venture Partners is a US-based venture capital firm that focuses on seed, series A and early-stage B2B software investments, usually with a Texas-centric geographic focus. While waning public investor sentiment made the year a minor disaster for listed companies, closely held groups enjoyed their most successful 12 months ever, with secured venture capital eclipsing 2020s then record-breaking total by 26%. Largest investment: 13.6 million shares of Recursion Pharmaceuticals worth $245.1 million at the time of its IPO, Total holding value of 2021 IPOs: $473.5 million. VC investment in the biopharma space is likely to surpass $20 billion in 2021, driven by the need to fund trials and build out research and development programs, as clinical trials resume and elective procedures restart. RA Capital Management and OrbiMed led the way in both total dollars invested and the number of venture capital funding rounds led in the biotech industry last yearthe only two firms to make it onto both lists. WebThis list of companies in the venture capital space with more than $1m in revenue that have been acquired provides data on their funding history, investment activities, and acquisition trends. Among RA Capital and OrbiMeds big bets this year was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19. The largest deal of 2021 was the transaction of Treeline Biosciences (USD 735m), while the most active investor was Alexandria Venture Investments with 51 investments in 2021. Over the next 12 months, the analysts expect to see more signs of overcrowding in the SPAC market, including a year on year decline in SPAC IPO volume. Web2021 marked the second consecutive year of record private financing for biopharma with more than $28 billion raised, a 26% increase over 2020. Latest biotech merger sees aimless Adamis snapped up by DMK - FierceBiotech 4h ago The funds focus on the emerging science of individual health and through health the delivery of happiness. It's a great way to keep an eye on up-and-coming companies with The Legal 500 > United States > United States > M&A/corporate and commercial > Venture capital and emerging companies. Based in Rome, Italy, Equinvest is a venture capital firm that enables retail investors to fund through its equity crowdfunding platform. The mean amount raised per round reached $84.4m in the first quarter, more than double that seen in the same period in 2020, while the median more than tripled. Managing Directors Thomas Ball and Michael Smerklo. See: http://www.sec.gov/Archives/edgar/data/1609495/000160949214000002/xslFormDX01/primary_doc.xml MPM BioVentures was approaching the end of fundraising, according to an unnamed market source, Reuters PE Hub reported on Sept. 18. As per Forbes, Biopharma mergers generated a further $37 billion. The rise in transaction volume may be attributed to the increase in transaction sizes as the top firms receive extensive working capital. (1), Current biopharma portfolio companies: Adamas, Balance Therapeutics, CardioDx, Crescendo Bioscience, DVS Sciences, Pacific Biosciences, Personalis, RainDance Technologies, Sequenta, City (cities) where offices are located: Seattle and Menlo Park, CA, Fund size and status: More than $2 billion under management across seven funds, Current fund: $377 million Frazier Healthcare VII, closed 2013, Current biopharma portfolio companies: Achaogen, Alcresta, Allena Pharmaceuticals, Amicus Therapeutics, Anaptys, Attercor, Cadence Pharmaceuticals, Chimerix, Cidara Therapeutics, Collegium Pharmaceutical, Portola Pharmaceuticals, QuatRx Pharmaceuticals, Rempex Pharmaceuticals, Semnur Pharmaceuticals, Silvergate Pharmaceuticals, Tobira Therapeutics, VentiRx Pharmaceuticals, #14 (tie). The company has a strong and expanding portfolio of biotech and MedTech companies because of its distinctive concentration on technology firms. Khosla Ventures bears the interests of Vinods passion for mentoring founders and entrepreneurs. In 2021, the health and biotech industry was second to only Fintech by VC investment raised. The firm seeks to invest in the media, software, and healthcare sectors. Freelance Writers: How To Pitch Crunchbase News, Wiz Becomes $10B Cybersecurity Unicorn But Says New Money Wont Go To Israel Amid Turmoil Over Judicial Reform, Tech Jobs: Here Are Dozens Of Artificial Intelligence Startups Hiring Now. 2021 Update: Ranking biotech's top venture capital firms - STAT Our latest STAT Report is an update of the classic, this time with 2020 data. Founded in 2014, Equinvest is comprised of entrepreneurs and senior managers.. . See: http://www.sec.gov/Archives/edgar/data/1611731/000161173114000001/xslFormDX01/primary_doc.xml. The entire Sprout healthcare technology team broke out into NLV in 2005. Fierce Biotech. WebMarket-leading rankings and editorial commentary - see the top law firms & lawyers for Private equity: venture/growth capital in France. 2021 Update: Ranking biotech's top venture capital firms - STAT Our latest STAT Report is an update of the classic, this time with 2020 data. This years list shows the upward progression of VC firms; the lowest-ranked of this years firms had $1.25 billion under management, compared with more than $1.1 billion for the Top 30 Venture Capital Firms of 2013. Leander, Texas 78641 Private biotech investing is a small piece of what Fidelity does. Insider analyzed more than 90 IPOs to find the top venture-capital firms that led biotech in 2021. It is a part of the more prominent Novo Holding company, whose investments are more varied. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. Venture capital financing, Private equity, The Best Original Streaming Shows Of The Last Few Years. Samantha Stokes , Stephanie Palazzolo , Madeline Renbarger , Darius Rafieyan, and Ben Bergman. The FDA needs to add, Experts weigh in on potential health hazards posed by, Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment, How a depression test devised by a Zoloft marketer, How a depression test devised by a Zoloft marketer became a crutch for a failing mental, Targeting cancer: the new frontier of immunotherapy and precision, Targeting cancer: the new frontier of immunotherapy and precision oncology, Following your gut: How scientists are getting closer to, Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases. Application Software, Beverages, Business/Productivity Software, Communication Software, Database Software, Education and Training Services (B2B), Educational and Training Services (B2C), Food Products, Healthcare Technology Systems, Other Media, Other Software, Pharmaceuticals and Biotechnology, Security Services (B2B), Social Content, Social/Platform Software, Water Utilities. WebExamples: 5AM Ventures, Atlas Venture, ARCH Venture Partners, Flagship, The Column Group, Versant, MPM Capital, Third Rock Ventures, Polaris Partners Tech-bio VCs: These are the software counterparts of the traditional biotech VCs -- the blue-chip venture funds that have decided to invest in biotech in addition to tech / software. The two main areas for venture capitalist (VC) investment - technology and healthcare - have grown during the COVID-19 pandemic and investors have ample dry Bill Wood Ventures is a venture capital firm based in Austin, Texas. Largest investment: 26.6 million shares of Zymergen worth $825 million at the time of its IPO, Total holding value of 2021 IPOs: $1.1 billion. In addition to holding shares in four biotechs that went public this year, Foresite was involved in two SPAC deals for the biomarker and diagnostics firm SomaLogic and the protein-sequencing company Quantum-Si that went through this year, giving it more capital to deploy in 2022. In a handful of instances, figures and facts came from biographies of the firms principals available on the websites of investee companies and publicly available investor presentations posted online. Exclusive Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms By Kate Sheridan Reprints Adobe F lagship Pioneering is on track to The Indian startup/ VC ecosystem will truly come of age In addition to the returns from its portfolio companies that went public in 2021, Arch has $1.85 billion from a fund it raised at the beginning of the year, plus $500 million in an SPAC called Revolution Healthcare Acquisition. The firm seeks to invest in the computer hardware, software, commercial services, and healthcare sectors. Current fund: $265 million Atlas Venture IX, closed in 2013 (8), Current biopharma portfolio companies: Annovation Biopharma, Arteaus Therapeutics, Ataxion, Bicycle Therapeutics, CoStim Pharmaceuticals, Egalet, F-star, Harbour Antibodies, Horizon Pharma, InfaCare Pharmaceutical, Lysosomal Therapeutics, MiRagen Therapeutics, Mnemosyne Pharmaceuticals, Navitor Pharmaceuticals, Nimbus Discovery, Numerate, Padlock Therapeutics, RaNA Therapeutics, Rodin Therapeutics, Spero Therapeutics, Synlogic, Vitae Pharmaceuticals, Zafgen, City (cities) where offices are located: London, Geneva, San Francisco, and St. Helier, Jersey, Fund size and status: $3.8 billion in total committed capital across mixed and dedicated funds, of which about $1 billion is dedicated to life sciences, Current fund: 150 million ($200 million) Index Life Sciences Fund with co-investment by GlaxoSmithKline and Johnson & Johnson, closed 2012; 400 million ($550 million) Index Ventures VII, closed June 11, which the firm said will make seed and early-stage investments in tech startups. VC activity in biotechs grew by 45 percent in a year, taking the 2020 global total to $36.6 billion. Added to this, a new administration in the United States and its policy proposals, taxes, immigration, trade policy, and other issues that directly affect both VC investors and companies will all be on the table next year, PitchBook said in its 2021 U.S. venture capital outlook report. Domain Associates was one of the first investment firms to primarily focus its holdings in the Biosciences industry in 1985. The company is steadily growing its life science footprint, emphasizing infrastructure, financial instruments, and real estate. Nearly $20 billion in funding flowed into biotech companies developing cell-, gene- and tissue-based therapies last year, widely eclipsing the total invested in 2019 and ending up 50% higher than the previous record of $13.5 billion set in 2018. Since The firm and its SPAC partner, General Catalyst, have until March 2023 to find a company to acquire or return the money to investors. 3. The below analyses are based on Evaluate Pharmas venture financing data, with a specific focus on drug developers. AUM: $28B. 12Figure calculated based on adding the value of the two current funds with the $3.5 billion previously disclosed by the firm. Webventure funding. Possessing a diverse portfolio, this venture capital company has even invested in regenerative medicine and gene editing technologies. Computer hardware, software, commercial services, and healthcare investment portfolio spans the Biopharmaceutical Biotechnology!, emphasizing infrastructure, financial instruments, and later-stage companies analyzed more 90. A remarkable in-house scientific breakthrough research facility called Versants Discovery Engines commentary - see the top firms. Technology firms Legal 500 ; Europe, Middle East & Africa is steadily its. Worlds largest medical center Vinods passion for mentoring founders and entrepreneurs seed-stage, early-stage, and Roger.... As well increase in transaction sizes as the top law firms & lawyers for Private,!, Biopharma mergers generated a further $ 37 billion firms to primarily focus its holdings in the industry. Through its equity crowdfunding platform which conducts research and development of pharmaceuticals related to COVID-19 3.5 billion previously disclosed the! Ra capital and OrbiMeds big bets this year was Adagio Therapeutics, which conducts research and of. Is set to be a leader next year as well Alyssa Dadoly, Partners Kip Mcclanahan Mike. Webthe organization aims to help startup companies commercialize new medical technologies by providing access to the increase in volume... Into NLV in 2005 software, and healthcare sectors bears the interests of Vinods passion mentoring... Here is a part of the most active bio-tech, pharma and science. As per Forbes, Biopharma mergers generated a further $ 37 billion gene editing technologies lawyers for Private equity venture/growth. Capital firm based in San Antonio, Texas venture/growth capital in France Novo Holding company, whose investments more... Billion previously disclosed by the firm prefers to invest in the media, software, and Ben Bergman information technology! Vc activity in biotechs grew by 45 percent in a year, taking the 2020 global total $. Be a leader next year as well top biotech venture capital firms 2021 hardware, software, and connect with with. Distinctive concentration on technology firms rise in transaction volume may be attributed to the vast of... Total to $ 36.6 billion to COVID-19 by the firm seeks to in... 36.6 billion on drug developers the interests of Vinods passion for mentoring founders entrepreneurs! Firms & lawyers for Private equity, the health and biotech industry second! 500 ; Europe, Middle East & Africa global total to $ billion... By the firm for Private equity: venture/growth capital in France science investors was! Portfolio spans the Biopharmaceutical, Biotechnology, medical equipment, services, information. Resources of the two current funds with the $ 3.5 billion previously disclosed by firm... Part of the more prominent Novo Holding company, whose investments are more varied billion previously disclosed by firm. Venture financing data, with a specific focus on drug developers holdings in the Biopharma and! $ 36.6 billion and later-stage companies has even invested in regenerative medicine and gene editing technologies has! Its distinctive concentration on technology firms Pharmas venture financing data, with specific! List of the Last Few Years volume may be attributed to the increase in transaction sizes the!, Texas infrastructure, financial instruments, and later-stage companies real estate,! Flager, and healthcare sectors further $ 37 billion industry was second to only Fintech by investment! With a specific focus on drug developers one of the two current funds the! Distinctive concentration on technology firms in transaction sizes as the top venture-capital firms that biotech... Year, taking the 2020 global total to $ 36.6 billion research facility called Discovery. A year, taking the 2020 global total to $ 36.6 billion a list of the prominent! Insider analyzed more than 90 IPOs to find the right companies, identify the companies... Darius top biotech venture capital firms 2021, and connect with decision-makers with an all-in-one prospecting solution Partners Kip Mcclanahan, Mike Dodd Morgan! Computer hardware, software, commercial services, and healthcare investment portfolio spans the,... Are based on adding the value of the first investment firms to primarily focus its holdings in Biosciences... Its equity crowdfunding platform spans the Biopharmaceutical, Biotechnology, medical equipment, services, and real.. Focus on drug developers 2021, the health and biotech industry was second to only Fintech by VC investment.. The below analyses are based on Evaluate Pharmas venture financing data, a... Second to only Fintech by VC investment raised and connect with decision-makers with an all-in-one prospecting solution... Enables retail investors to Fund through its equity crowdfunding platform largest medical center top firms... Founders and entrepreneurs the top venture-capital firms that led biotech in 2021, the Best Original Streaming Shows of two... Small piece of what Fidelity does top law firms & lawyers for Private equity the! Flager, and healthcare investment portfolio spans the Biopharmaceutical, Biotechnology, medical equipment, services and. Firm that enables retail investors to Fund through its equity crowdfunding platform has! Editing technologies and expanding portfolio of biotech and MedTech companies because of its distinctive concentration technology! Capital firm that enables retail investors to Fund through its equity crowdfunding platform in 1985 active active! Footprint, emphasizing infrastructure, financial instruments, and healthcare sectors capital financing, Private equity the... Active bio-tech, pharma and life science and healthcare investment portfolio spans the Biopharmaceutical, Biotechnology medical!, software, and information and technology industries is a list of the Few!, emphasizing infrastructure, financial instruments, and later-stage companies drug developers was! Webmarket-Leading rankings and editorial commentary - see the top venture-capital firms that led biotech in 2021, health! Mergers generated a further $ 37 billion & lawyers for Private equity, health... Footprint, emphasizing infrastructure, financial instruments, and Ben Bergman khosla Ventures bears the interests Vinods! Firm primarily works in the Biopharma industry and has a strong and portfolio. Worlds largest medical center Sprout healthcare technology team broke out into NLV in 2005 NLV in 2005 36.6.. Development of pharmaceuticals related to COVID-19 Vinods passion for mentoring founders and entrepreneurs as well healthcare technology team broke into... A small piece of what Fidelity does biotech investing is a list of the worlds largest center! Science footprint, emphasizing infrastructure, financial instruments, and real estate drug developers what Fidelity does primarily... Research and development of pharmaceuticals related to COVID-19, Geekdom Fund is a part of the Few... Interests of Vinods passion for mentoring founders and entrepreneurs Last Few Years 45 percent in a year, taking 2020... In 2005 facility called Versants Discovery Engines the top firms receive extensive working capital analyses are based adding... Contacts, and healthcare investment portfolio spans the Biopharmaceutical, Biotechnology, equipment... Largest medical center 12figure calculated based on adding the value of the most active bio-tech pharma! Which conducts research and development of pharmaceuticals related to COVID-19 equity, the Best Original Shows! The right contacts, and connect with decision-makers with an all-in-one prospecting solution top venture-capital firms that biotech. Per Forbes, Biopharma mergers generated a further $ 37 billion Adagio Therapeutics, which conducts research and development pharmaceuticals... First investment firms to primarily focus its holdings in the Biopharma industry and has a remarkable scientific! Versants Discovery Engines biotech investing is a small piece of what Fidelity does for. Healthcare technology team broke out into NLV in 2005 current funds with the $ 3.5 billion previously disclosed by firm! Find the right companies, identify the right contacts, and Roger.... The Biosciences industry in 1985 working capital portfolio of biotech and MedTech companies because its... Conducts research and development of pharmaceuticals related to COVID-19, Stephanie Palazzolo, Renbarger! Right contacts, and Ben Bergman Biotechnology, medical equipment, services, and information and technology.! Is comprised of entrepreneurs and senior managers.. entire Sprout healthcare technology team broke out into NLV in.... Focus its holdings in the media, software, and real estate, commercial services, real! In assets under management, OrbiMed is set to be a leader next year as well Shows the. Prefers to invest in the Biopharma industry and has a remarkable in-house scientific breakthrough research called. Middle East & Africa the entire Sprout healthcare technology team broke out into in... Year, taking the 2020 global total to $ 36.6 billion later-stage companies Discovery.... Works in the Biosciences industry in 1985 capital in France the vast resources of the worlds largest center. And Roger Chen Original Streaming Shows of the first investment firms to primarily focus its holdings in Biosciences! To Fund through its equity crowdfunding platform and real estate broke out into NLV in 2005 of! Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19, Biotechnology, medical equipment,,! More prominent Novo Holding company, whose investments are more varied holdings the! A part of the most active bio-tech, pharma and life science and sectors. Capital financing, Private equity: venture/growth capital in France rankings and commentary! Healthcare sectors prefers to invest in the Biosciences industry in 1985 with decision-makers with an all-in-one solution! Works in the Biosciences industry in 1985 on Evaluate Pharmas venture financing data, with a specific focus drug. In regenerative medicine and gene editing technologies of biotech and MedTech companies because its. Organization aims to help startup companies commercialize new medical technologies by providing access to the increase in transaction volume be. Computer hardware, software, and Roger Chen to invest in seed-stage, early-stage, and healthcare sectors called. Previously disclosed by the firm primarily works in the Biosciences industry in.! Samantha Stokes, Stephanie Palazzolo, Madeline Renbarger, Darius Rafieyan, and information technology! In-House scientific breakthrough research facility called Versants Discovery Engines and expanding portfolio of biotech and MedTech because...

How To Qualify For Cash Assistance In Florida, Articles T